BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19150968)

  • 1. Development and evaluation of a computerized test battery for Alzheimer's disease screening in community-based settings.
    Inoue M; Jinbo D; Nakamura Y; Taniguchi M; Urakami K
    Am J Alzheimers Dis Other Demen; 2009; 24(2):129-35. PubMed ID: 19150968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Validation Study of the Inbrain CST: a Tablet Computer-based Cognitive Screening Test for Elderly People with Cognitive Impairment.
    Chin J; Kim DE; Lee H; Yun J; Lee BH; Park J; Yeom J; Shin DS; Na DL
    J Korean Med Sci; 2020 Aug; 35(34):e292. PubMed ID: 32864906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities.
    Yang H; Cheng Z; Li Z; Jiang Y; Zhao J; Wu Y; Gu S; Xu H
    Int J Geriatr Psychiatry; 2019 Nov; 34(11):1658-1666. PubMed ID: 31347192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Chinese version of story recall: a useful screening tool for mild cognitive impairment and Alzheimer's disease in the elderly.
    Shi J; Wei M; Tian J; Snowden J; Zhang X; Ni J; Li T; Jian W; Ma C; Tong Y; Liu J; Liu T; Wang P; Wang Y
    BMC Psychiatry; 2014 Mar; 14():71. PubMed ID: 24612772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computerized Cognitive Screen (CoCoSc): A Self-Administered Computerized Test for Screening for Cognitive Impairment in Community Social Centers.
    Wong A; Fong CH; Mok VC; Leung KT; Tong RK
    J Alzheimers Dis; 2017; 59(4):1299-1306. PubMed ID: 28731437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of the quantitative EEG statistical pattern recognition method in diagnosing Alzheimer's disease.
    Ommundsen N; Engedal K; Øksengård AR
    Dement Geriatr Cogn Disord; 2011; 31(3):195-201. PubMed ID: 21430383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a community setting.
    Fage BA; Chan CC; Gill SS; Noel-Storr AH; Herrmann N; Smailagic N; Nikolaou V; Seitz DP
    Cochrane Database Syst Rev; 2015 Feb; (2):CD010860. PubMed ID: 25922857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for Alzheimer's disease with the short cognitive evaluation battery.
    Robert PH; Schuck S; Dubois B; Olié JP; Lépine JP; Gallarda T; Goni S; Troy S;
    Dement Geriatr Cogn Disord; 2003; 15(2):92-8. PubMed ID: 12566598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 7 minute neurocognitive screening battery highly sensitive to Alzheimer's disease.
    Solomon PR; Hirschoff A; Kelly B; Relin M; Brush M; DeVeaux RD; Pendlebury WW
    Arch Neurol; 1998 Mar; 55(3):349-55. PubMed ID: 9520009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardized evaluation of algorithms for computer-aided diagnosis of dementia based on structural MRI: the CADDementia challenge.
    Bron EE; Smits M; van der Flier WM; Vrenken H; Barkhof F; Scheltens P; Papma JM; Steketee RM; Méndez Orellana C; Meijboom R; Pinto M; Meireles JR; Garrett C; Bastos-Leite AJ; Abdulkadir A; Ronneberger O; Amoroso N; Bellotti R; Cárdenas-Peña D; Álvarez-Meza AM; Dolph CV; Iftekharuddin KM; Eskildsen SF; Coupé P; Fonov VS; Franke K; Gaser C; Ledig C; Guerrero R; Tong T; Gray KR; Moradi E; Tohka J; Routier A; Durrleman S; Sarica A; Di Fatta G; Sensi F; Chincarini A; Smith GM; Stoyanov ZV; Sørensen L; Nielsen M; Tangaro S; Inglese P; Wachinger C; Reuter M; van Swieten JC; Niessen WJ; Klein S;
    Neuroimage; 2015 May; 111():562-79. PubMed ID: 25652394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data from a longitudinal study provided measurements of cognition to screen for Alzheimer's disease.
    Brant LJ; Sheng SL; Morrell CH; Zonderman AB
    J Clin Epidemiol; 2005 Jul; 58(7):701-7. PubMed ID: 15939221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of dementia screening tests with biomarkers of Alzheimer's disease.
    Galvin JE; Fagan AM; Holtzman DM; Mintun MA; Morris JC
    Brain; 2010 Nov; 133(11):3290-300. PubMed ID: 20823087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of CogEvo, a computerized cognitive assessment and training tool, for distinguishing patients with mild Alzheimer's disease and mild cognitive impairment from cognitively normal older people.
    Takechi H; Yoshino H
    Geriatr Gerontol Int; 2021 Feb; 21(2):192-196. PubMed ID: 33336432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Screening Utility and Ecological Validity of the Neuropsychological Assessment Battery Bill Payment Subtest in Older Adults with and without Dementia.
    Kenney LE; Margolis SA; Davis JD; Tremont G
    Arch Clin Neuropsychol; 2019 Oct; 34(7):1156-1164. PubMed ID: 31504079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Education-Based Cutoffs for Cognitive Screening of Alzheimer's Disease.
    Alenius M; Ngandu T; Koskinen S; Hallikainen I; Hänninen T; Karrasch M; Kivipelto M; Raivio MM; Laakkonen ML; Krüger J; Suhonen NM; Hokkanen L
    Dement Geriatr Cogn Disord; 2022; 51(1):42-55. PubMed ID: 35196653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.
    Pinto TCC; Machado L; Costa MLG; Santos MSP; Bulgacov TM; Rolim APP; Silva GA; Rodrigues-Júnior AL; Sougey EB; Ximenes RCC
    Dement Geriatr Cogn Disord; 2019; 47(4-6):366-374. PubMed ID: 31466064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for dementia by telephone using the memory impairment screen.
    Lipton RB; Katz MJ; Kuslansky G; Sliwinski MJ; Stewart WF; Verghese J; Crystal HA; Buschke H
    J Am Geriatr Soc; 2003 Oct; 51(10):1382-90. PubMed ID: 14511157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validity of the Computer-Based Cognitive Assessment Tool for intervention in community-dwelling older individuals.
    Takahashi J; Kawai H; Suzuki H; Fujiwara Y; Watanabe Y; Hirano H; Kim H; Ihara K; Miki A; Obuchi S
    Geriatr Gerontol Int; 2020 Mar; 20(3):171-175. PubMed ID: 31916344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.